Anti-gram positive agents of natural product origins

Comprehensive Medicinal Chemistry II

Volumn 7, Issue , 2006, Pages 653-671

  Lee, V J ^a  

^a Adesis Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906438313     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Williams, D. H.; Stone, M. J.; Hauck, P. R.; Rahman, S. K. J. Nat. Prod. 1989, 52, 1189-1208.
2. Vining, L. C. Annu. Rev. Microbiol. 1990, 44, 395-427.
3. Woodruff, H. B.; Hernandez, S.; Scapley, E. D. Hindustan Antibiot. Bull 1979, 21, 71-84.
4. Verdine, G. L. Nature 1996, 384, 11-13.
5. Singh, M. R; Greenscein, M. Curr. Opin. Drug Disc. Dev. 2000, 3, 167-176.
6. Kirby, W M. M. Science 1944, 99, 452-453.
7. Chambers, H. E. Clin. Microbiol. Rév. 1997, 10, 789-791.
8. Noble, W C.; Virani, Z.; Cree, R. G. FEMS Microbiol. Lett. 1992, 12, 195-198.
9. Fontana, R.; Cerini, R.; Longoni, R; Grossato, A.; Canepari, R. J. Bacteriol. 1983, 155, 1343-1350.
10. Williamson, R.; le Bouguenec, C.; Gutmann, L.; Horaud, T. J. Gen. Microbiol. 1985, 131, 1933-1940.
11. Reichmann, R; König, A.; Marton, A.; Hakenbeck, R. Microb. Drug Resist. 1996, 2, 177-181.
12. Hakenbeck, R.; König, A.; Kern, I.; van der Linden, M.; Keck, W; Billot-Klein, D.; Legrand, R.; Schoo, B.; Gutmann, L. J. Bacteriol. 1998, 180, 1831-1840.
13. Smith, T L.; Pearson, M. L.; Wilcox, K. R.; Cruz, C.; Lancaster, M. V; Robinson-Dunn, B.; Tenover, E C.; Zervos, M. J.; Band, J. D.; White, E. et al. N. Engl J. Med. 1999, 340, 493-501.
14. Sieradzki, K.; Roberts, R. B.; Haber, S. W; Tomasz, A. N Engl J. Med. 1999, 340, 517-523.
15. Chang, S.; Sievert, D.; Hageman, J.; Boulton, M. L.; Tenover, F C.; Downes, F R; Shah, S.; Rudrik, J. T.; Pupp, G. R.; Brown, W J.; et al. N. Engl. J. Med. 2003, 348, 1342-1347.
16. Kirst, H. A.; Thompson, D. G.; Nicas, T. I. Antimicrob. Agents Chemother. 1998, 42, 1303-1304.
17. Moellering, R. C., Jr. J. Antimicrob. Chemother. 1991, 28, 1-12.
18. Frieden, T R.; Munsiff, S. S.; Low, D. E.; Willey, B. M.; Williams, G.; Faur, Y; Eisner, W; Warren, S.; Kreiswirth, B. Lancet 1993, 342, 76-79. lib.
19. Boyce, J. M. Infect. Dis. Clin. North Am. 1997, 11, 367-384.
20. Walsh, C. T; Fisher, S. L.; Park, I. S.; Prahalad, M.; Wu, Z. Chem. Biol 1996, 3, 21-28.
21. Bager, F; Madsen, M.; Christensen, J.; Aarestrup, F M. Prev. Vet. Med. 1997, 31, 95-112.
22. Wegener, H. C.; Aarestrup, F M.; Jensen, L. B.; Hammerum, A. M.; Bager, F. Emerg. Infect. Dis. 1999, 5, 329-335.
23. Hermann, R.; Ripamonti, F; Romano, G.; Restelli, E.; Ferrari, P; Goldstein, B. P.; Berti, M.; Ciabatti, R. J. J. Antibiot. (Tokyo) 1996, 49, 1236-1248.
24. Cooper, R. D.; Snyder, N. J.; Zweifel, M. J.; Staszak, M. A.; Wilkie, S. C.; Nicas, T I.; Mullen, D. L.; Butler, T. F; Rodriguez, M. J.; Huff, B. E. et al. J. Antibiot. (Tokyo) 1996, 49, 575-581.
25. Leadbetter, M. R.; Adams, S. M.; Bazzini, B.; Fatheree, P. R.; Karr, D. E.; Krause, K. M.; Lam, B. M. T; Linsell, M. S.; Nodwell, M. B.; Pace, J. L. et al. J. Antibiot. (Tokyo) 2004, 57, 326-336.
26. Van Bambeke, F; Laethem, Y V; Courvalin, P; Tulkens, P. M. Drugs 2004, 64, 913-936.
27. Zelenitsky, S. A.; Karlowsky, J. A.; Zhanel, G. G.; Hoban, D. J.; Nicas, T. Antimicrob. Agents Chemother. 1997, 41, 1407-1408.
28. Goldstein, B. P; Selva, E.; Gastaldo, L.; Berti, M.; Pallanza, R.; Ripamonti, F; Ferrari, P.; Denaro, M.; Arioli, V; Cassani, G. Antimicrob. Agents Chemother. 1987, 31, 1961-1966.
29. Malabarba, A.; Ciabatti, R.; Kettenring, J.; Ferrari, P.; Scotti, R.; Goldstein, B. P; Denaro, M. J. Antibiot. (Tokyo) 1994, 47, 1493-1506.
30. Mackey, J. P; Gerhard, U.; Beauregard, D. A.; Williams, D. H.; Westwell, M. S.; Searle, M. S. J. Am. Chem. Soc. 1994, 116, 4581-4590.
31. Beauregard, D. A.; Williams, D. H.; Gwynn, M. N.; Knowles, D. J. Antimicrob. Agents Chemother. 1995, 39, 781-785.
32. Printsevskaya, S. S.; Pavlov, A. Y; Olsufyeva, E. N.; Mirchink, E. P.; Preobrazhenskaya, M. N. J. Med. Chem. 2003, 46, 1204-1209.
33. Van Bambeke, F; Saffran, J.; Mingeot-Leclercq, M.-P; Tulkens, P M. Antimicrob. Agents Chemother. 2005, 49, 1695-1700.
34. Pace, J. L.; Krause, K.; Johnston, D.; Debabov, D.; Wu, T; Farrington, L.; Higgins, D. L. L.; Christensen, B.; Judice, J. K.; Koniga, K. Antimicrob. Agents Chemother. 2003, 47, 3602-3604.
35. Candiani, G.; Abbondi, M.; Borgonovi, M.; Roman, G.; Parenti, F. J. Antimicrob. Chemother. 1999, 44, 179-192.
36. King, A.; Phillips, I.; Kaniga, K. J. Antimicrob. Chemother. 2004, 53, 797-803.
37. Dorr, M. B.; Jabes, D.; Cavaleri, M.; Dowell, J.; Mosconi, G.; Malabarba, A.; White, R. J.; Henkel, T J. J. Antimicrob. Chemother. 2005, 55, i125-i130.
38. Fuller, A. T; Mellows, G.; Woolford, M.; Banks, G. T; Barrow, K. D.; Chain, E. B. Nature 1971, 234, 416-417.
39. Slocombe, B.; Perry, C. J. Hosp. Infect. 1991 (Suppl B) 19-25.
40. Silvian, L. F; Wang, J.; Steitz, T A. Science 1999, 285, 1074-1077.
41. Gilbart, J.; Perry, C. R.; Slocombe, B. Antimicrob. Agents Chemother. 1993, 37, 32-38.
42. Udo, E. E.; Farook, V. S.; Eiman, M.; Mokadas, E. M.; Jacob, L. E.; Sanyal, S. C. Int. J. Infect. Dis. 1999, 3, 82-87.
43. Klein, L. L.; Yeung, C. M.; Kurath, P; Mao, J. C.; Fernandes, P. B.; Lartey, P. A.; Pernet, A. G. J. Med. Chem. 1989, 32, 151-160.
44. Brown, P; Davies, D. T.; O'Hanlon, P. J.; Wilson, J. M. J. Med. Chem. 1996, 39, 446-457.
45. Broom, N. J. P.; Cassels, R.; Cheng, H.-Y; Elder, J. S.; Hannan, P. C. T.; Masson, N.; O'Hanlon, P. J.; Pope, A.; Wilson, J. M. J. Med. Chem. 1996, 39, 3596-3600.
46. Brown, P; Best, D.; Broom, N. J. P.; Cassels, R.; Mitchell, T J.; Osborne, N. F; Wilson, J. M. J. Med. Chem. 1997, 40, 2563-2570.
47. Barriere, J. C.; Berthaud, N.; Beyer, D.; Dutka-Malen, S.; Paris, J. M.; Desnottes, J. F. Curr. Pharm. Des 1998, 4, 155-180.
48. Berthaud, N.; Charles, Y; Gouin, A.-M.; Mereau, B.; Rousseau, J.; Desnottes, J.-F; Macgowan, A.P. RPR 106972, A New Oral Streptogramin·. In Vitro Antibacterial Activity. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1995; Abs F112.
49. Spangler, S. K.; Jacobs, M. R.; Appelbaum, P C. Antimicrob. Agents Chemother. 1996, 40, 481-484.
50. Debono, M.; Barnhart, M.; Carrell, C. B.; Hoffman, J. A.; Occolowitz, J. L.; Abbott, B. J.; Fukuda, D. S.; Hamill, R. L.; Biemann, K.; Herlihy, W. C. J. Antibiot. (Tokyo) 1987, 40, 761-777.
51. Baltz, R. H.; Miao, V; Wrigley, S. K. Nat. Prod. Rep. 2005, 22, 717-741.
52. Howe, R. A.; Noel, A. R.; Tomaselli, S.; Bowker, K. E.; Walsh, T R.; Macgowan, A. P. Killing Activity of Daptomycin against Vancomycin Intermediate Staphylococcus aureus (VISA) and Hetero-VISA. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Sept 14-17, 2003; Abs C1-1641.
53. Rybak, M. J.; Hershberger, E.; Moldovan, T; Grucz, R. G. Antimicrob. Agents Chemother. 2000, 44, 1062-1066.
54. Streit, J. M.; Jones, R. N.; Sader, H. S. J. Antimicrob. Chemother. 2004, 53, 669-674.
55. Debono, M.; Abbott, B. J.; Molloy, R. M.; Fukuda, D. S.; Hunt, A. H.; Daupert, V M.; Counter, F T; Ott, J. L.; Carrell, C. B.; Howard, L. C. et al. J. Antibiot. (Tokyo) 1988, 41, 1093-1105.
56. Silverman, J. A.; Perlmutter, N. G.; Shapiro, H. M. Antimicrob. Agents Chemother. 2003, 47, 2538-2544.
57. Carpenter, C. F; Chambers, H. F. Clin. Infect. Dis. 2004, 38, 994-1000.
58. Heinemann, B.; Kaplan, M. A.; Muir, R. D.; Hooper, I. R. Antibiot. Chemother. 1953, 3, 1239-1242.
59. Vertesy, L.; Ehlers, E.; Kogler, H.; Kurz, M.; Meiwes, J.; Seibert, G.; Vogel, M.; Hammann., P. J. Antibiot. (Tokyo) 2000, 53, 816-827.
60. Banerjee, D. K. J. Biol. Chem. 1989, 264, 2024-2028.
61. Cameron, D. R.; Chen, Y.; Dugourd, D.; Sun, J.; Wang, L.; Borders, D. B.; Curran, W. V; Leese, R. A. New Laspartomycin-BasedSemi-Synthetic Lipopeptide Antibiotics. 229th American Chemical Society Meeting, San Diego, CA, Mar 13-17, 2005; Abs 358.
62. Wacowich-Sgarbi, S. A.; Boyd, V A.; Cameron, D. R.; Chen, Y.; Dugourd, D.; Jia, Q.; Nodwell, M.; Sgarbi, P. W. M.; Sun, J.; Wang, L. et al. Synthesis and Structure-Activity Relationship (SAR) Studies on Dab-9 Substitutions of the Lipopeptide Antibiotic Amphomycin. 229th American Chemical Society Meeting, San Diego, CA, Mar 13-17, 2005; Abs 367.
63. Sgarbi, P. W M.; Boyd, V A.; Cameron, D. R.; Chen, Y.; Jia, Q.; Nodwell, M.; Siu, R.; Sun, J.; Wacowich-Sgarbi, S. A.; Wang, L. et al. Synthesis and Structure-Activity Relationship (SAR) Studies on the Lipophilic Tail of the Lipopeptide Antibiotic Amphomycin. 229th American Chemical Society Meeting, San Diego, CA, Mar 13-17, 2005; Abs 368.
64. Rubinchik, E.; Pasetka, C. J.; Liu, B.; Omilusik, K. D.; Scott, A.; Cameron, D. R.; Boyd, V A.; Borders, D. B.; Leese, R. A.; Curran, W V et al. Novel Antimicrobial Lipopeptides with Long In vivo Half-Lives. 105 th General Meeting of American Society of Microbiology, Atlanta, GA, June 5-9, 2005; Abs A-056.
65. Cameron, D. R.; Boyd, V A.; Leese, R. A.; Curran, W V; Francis, N. D.; Jarolmen, H.; Borders, D. B.; Sgarbi, P. W M.; Wacowich-Sgarbi, S. A.; Nodwell, M. et al. Compositions of Lipopeptide Antibiotics and Methods of Use Thereof, WO 05/000878; US 2005/153876, Filed June 28,2004.
66. Fardis, M.; Cameron, D. R.; Boyd, V A. Dab9 Derivatives of Lipopeptide Antibiotics and Methods of Making and Using the Same, WO 03/057724; US 2004/138107, Filed Jan 3,2003.
67. Cavalleri, B.; Pagani, H.; Volpe, G.; Selva, E.; Parenti, F. J. Antibiot. (Tokyo) 1984, 37, 309-317.
68. Pallanza, R.; Berti, M.; Scotti, R.; Randisi, E.; Arioli, V. J. Antibiot. (Tokyo) 1984, 37, 318-324.
69. Jiang, W; Wanner, J.; Lee, R. J.; Bounaud, P-Y; Boger, D. L. J. Am. Chem. Soc. 2002, 124, 5288-5290.
70. Montecalvo, M. J. Antimicrob. Chem. 2003, 51, ii131-ii135.
71. Hu, Y; Helm, J. S.; Chen, L.; Ye, X.-Y; Walker, S. J. Am. Chem. Soc. 2003, 125, 8736-8737.
72. Collins, L. A.; Eliopoulos, G. M.; Wennersten, C. B.; Ferraro, M. J.; Moellering, R. C. Antimicrob. Agent Chemother. 1993, 37, 1364-1366.
73. Mobarakai, N.; Quile, J. M.; Landman, D. Antimicrob. Agents Chemother. 1994, 38, 385-387.
74. Johnson, C. C.; Taylor, S.; Pitsakis, P; May, P; Levinson, M. E. Antimicrob. Agents Chemother. 1992, 36, 2342-2345.
75. Wong, M. T; Kauffman, C. A.; Standiford, H. C.; Linden, P; Fort, G.; Fuchs, H. J.; Porter, S. B.; Wenzel, R. P.; Ramoplanin VRE Clinical Study Group. Clin. Infect. Dis. 2001, 33, 1476-1482.
76. Weinstein, M. J.; Luedemann, G. M.; Oden, E. M.; Wagman, G. H. Antimicrob. Agents Chemother. 1964, 10, 24-32.
77. Ganguly, A. K.; Sarre, O. Z.; Greeves, D.; Morton, J. J. Am. Chem. Soc. 1975, 97, 1982-1985.
78. Jones, R. N.; Hare, R. S.; Sabatelli, F J. Ziracin Susceptibility Testing Group. J. Antimicrob. Chemother. 2001, 47, 15-25.
79. McNicholas, P M.; Najarian, D. J.; Mann, P A.; Hesk, D.; Hare, R. S.; Shaw, K. J.; Black, T A. Antimicrob. Agents Chemother. 2000, 44, 1121-1126.